In animal and cell models of NAFLD, MALAT1 expression was higher, and this upregulation caused an increase of Srebf1 mRNA and protein expression and promoted hepatic steatosis [156]. Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.